| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |